Batroxidase has the effect of lowering fibrinogen, and there is a possibility of bleeding after using the drug, so it should not be transfused too quickly.
Batroxidase is a western medicine, commonly used in the form of injection, as an anticoagulant. It can be used to treat acute cerebral infarction, but also to treat the improvement of ischemic symptoms, peripheral and microcirculatory disorders caused by various occlusive vascular diseases.
Batroxidase can cause subcutaneous bleeding, delayed hemostasis, vasopain, chest pain, fever, chills, epicarditis, nasal congestion, elevated BUN, elevated serum creatinine, and proteinuria. Contraindicated in patients with bleeding. Contraindicated in patients with recent surgery. This preparation has a fibrinogen-lowering effect, and bleeding or delayed hemostasis may occur after administration.
Batroxidase is an anticoagulant, this preparation has the effect of reducing fibrinogen, bleeding or delayed hemostasis may occur after use of the drug, so it can not be transfused too fast. If you need to use the drug, you need to use under the guidance of a doctor, do not use the drug on your own to avoid adverse effects on the body.